April 23, 2013
A North Carolina federal judge on Tuesday granted a permanent injunction to Allergan Inc. and Duke University against several planned generic versions of eyelash growth stimulant Latisse after previously finding the proposed drugs infringed on two patents, disregarding the protests of the generic-drug makers.
January 30, 2013
A North Carolina federal judge has blocked the release of generic versions of Allergan Inc. and Duke University's Latisse eyelash growth stimulant, ruling three generics makers had infringed two Allergan and Duke patents.
April 18, 2011
Allergan Inc. launched a patent infringement suit Friday in a North Carolina federal court over Sandoz Inc.'s efforts to manufacture a generic version of Latisse, a treatment to stimulate eyelash growth.